Replies to post #6176 on Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[Rymankoly]

I think KTOV advantage might be that KIT-302 is a combination of 2 prescription drugs and not OTC (like Horizon's drug).

But I still think the market will be more challenging, due to higher public awareness of price gauging by drug companies.
Still, they don't need much for success.....(I got a small position, but might increase it, based on future development).